ScoreWhy is Standard BioTools, Inc. ?
1
Poor long term growth as Operating profit has grown by an annual rate -164.21% of over the last 5 years
2
With a fall in EPS of -28.42%, the company declared Very Negative results in Jun 25
- NET SALES(Q) Lowest at USD 21.76 MM
3
Risky - Negative EBITDA
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -12.35%, its profits have fallen by -97.9%
4
Underperformed the market in the last 1 year
- Even though the market (S&P 500) has generated returns of 12.33% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -12.35% returns
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Standard BioTools, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Standard BioTools, Inc.
-21.31%
-0.54
76.14%
S&P 500
13.22%
0.61
20.17%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
6.49%
EBIT Growth (5y)
-164.21%
EBIT to Interest (avg)
-41.96
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.55
Sales to Capital Employed (avg)
0.34
Tax Ratio
0.22%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
85.02%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.89
EV to EBIT
-1.20
EV to EBITDA
-1.37
EV to Capital Employed
0.74
EV to Sales
0.89
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-62.17%
ROE (Latest)
-24.43%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend8What is working for the Company
RAW MATERIAL COST(Y)
Fallen by -6.03% (YoY
PRE-TAX PROFIT(Q)
Highest at USD -16.28 MM
NET PROFIT(Q)
Highest at USD -15.67 MM
-7What is not working for the Company
NET SALES(Q)
Lowest at USD 21.76 MM
Here's what is working for Standard BioTools, Inc.
Pre-Tax Profit
Highest at USD -16.28 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (USD MM)
Pre-Tax Profit
At USD -16.28 MM has Grown at 56.15%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (USD MM)
Net Profit
Highest at USD -15.67 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
Net Profit
At USD -15.67 MM has Grown at 57.85%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is positive
Net Profit (USD MM)
Raw Material Cost
Fallen by -6.03% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Standard BioTools, Inc.
Net Sales
At USD 21.76 MM has Fallen at -41.51%
Year on Year (YoY)MOJO Watch
Near term sales trend is extremely negative
Net Sales (USD MM)
Net Sales
Lowest at USD 21.76 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (USD MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
